We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ALA Launches Spotlight Series in Partnership with Symyx Technologies and Thermo Fisher Scientific

News   Jul 25, 2007

 
ALA Launches Spotlight Series in Partnership with Symyx Technologies and Thermo Fisher Scientific
 
 
 

RELATED ARTICLES

Pancreatic Cancer: Mechanism of treatment-resistance discovered

News

Despite decades of research, treatments that can target a common mutation in the most frequently diagnosed type of pancreatic cancer have remained elusive. Now, researchers report they have discovered a mechanism of resistance to a treatment they’d identified as promising.

READ MORE

Drug Candidate Could Recover Vocal Abilities Lost to ADNP Syndrome

News

A new Tel Aviv University study finds that the drug candidate CP201, also known as NAP, may improve vocal communication abilities that are underdeveloped in Activity-dependent neuroprotective protein (ADNP) patients.

READ MORE

Molecular Mechanisms of Ancient Herbal Remedies

News

Analysis of leaf extract reveals novel chemistry for therapeutic ion channel activation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE